Research
Dr. DeRyckere's research focuses on development of novel therapies targeting the TAM-family receptor tyrosine kinases for treatment of a variety of cancers. Deb DeRyckere is investigating a new drug target in childhood leukemias and solid tumors and developing MRX-2843, now in clinical trials, with the potential to greatly improve outcomes for children and young adults facing these cancers.
Research Interest Keywords
leukemia, breast cancer, lung cancer, immunotherapy, targeted therapies